
Bill Maughan
analystMale0.0Global Dominance: 0.00%
Bill Maughan is a Clear Street analyst who has expressed concern over the impact of political changes on the vaccine sector, indicating that investment confidence in biotech companies, particularly those focused on vaccines, has been undermined by recent policy shifts under US Secretary of Health and Human Services Robert F. Kennedy Jr.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Bill Maughan is a Clear Street analyst who commented on the challenges facing biotech investors in the current vaccine landscape.
Drugmakers take hit from the US’ anti-vax changesTaipei Times – major English newspaper in Taiwan, est. 1999·
Taiwan· 2026-01-25






